olmesartan has been researched along with Hypotension in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kario, K; Kushiro, T; Mori, Y; Okuda, Y; Saito, I; Shimada, K; Teramukai, S; Yaginuma, M; Zenimura, N | 1 |
| Arimura, T; Imaizumi, S; Iwata, A; Kuwano, T; Matsuo, Y; Miura, S; Saku, K; Suematsu, Y; Uehara, Y; Yahiro, E | 1 |
| Ideno, S; Kobari, M; Nakada, T; Oiwa, T; Yaguchi, A | 1 |
| Masonson, HN; Schwocho, LR | 1 |
1 trial(s) available for olmesartan and Hypotension
| Article | Year |
|---|---|
Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects.
Topics: Administration, Oral; Adult; Angiotensin Receptor Antagonists; Area Under Curve; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypotension; Imidazoles; Infusions, Intravenous; Liver; Male; Metabolic Clearance Rate; Musculoskeletal Diseases; Olmesartan Medoxomil; Pain; Tablets; Tetrazoles; Transaminases | 2001 |
3 other study(ies) available for olmesartan and Hypotension
| Article | Year |
|---|---|
Home blood pressure and cardiovascular outcomes in very elderly patients receiving antihypertensive drug therapy: a subgroup analysis of Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure (HONEST) st
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Female; Follow-Up Studies; Humans; Hypertension; Hypotension; Imidazoles; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Proportional Hazards Models; Prospective Studies; Risk Factors; Risk Reduction Behavior; Systole; Tetrazoles | 2018 |
Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cell Culture Techniques; Hypotension; Imidazoles; Inositol Phosphates; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Donors; Tetrazoles | 2015 |
[Case of olmesartan and amlodipine intoxication].
Topics: Acid-Base Imbalance; Amlodipine; Angiotensin II Type 2 Receptor Blockers; Calcium Gluconate; Drug Overdose; Female; Humans; Hypotension; Imidazoles; Middle Aged; Norepinephrine; Tetrazoles; Treatment Outcome; Water-Electrolyte Imbalance | 2011 |